American Society of Clinical Oncology

SHERPA: White

People

  1. Ostrovnaya
    Ostrovnaya
  2. Bajorin
    Bajorin
  3. Iyer
    Iyer
  4. Regazzi
    Regazzi
  5. Rosenberg
    Rosenberg
  6. Bochner
    Bochner
  7. Solit
    Solit
  8. Al-Ahmadie
    Al-Ahmadie
  9. Funt
    Funt
  10. Teo
    Teo

Groups

  1. Biostatistics Service (67)
  2. Epidemiology and Biostatistics (67)
  3. Department of Medicine (62)
  4. Solid Tumor Oncology Division (62)
  5. Genitourinary Oncology Service (56)
  6. GSK Faculty (38)
  7. Surgery (32)
  8. Urology (30)
  9. Survivorship Research (22)
  10. Human Oncology and Pathogenesis Program (18)
Search Within
  1. "Irina Ostrovnaya"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (14)
Groups
  1. Biostatistics Service (67)
  2. Epidemiology and Biostatistics (67)
  3. Department of Medicine (62)
  4. Solid Tumor Oncology Division (62)
  5. Genitourinary Oncology Service (56)
  6. GSK Faculty (38)

More Groups

People
  1. Irina Ostrovnaya (67)
  2. Dean Bajorin (43)
  3. Ashley Regazzi (28)
  4. Gopakumar Iyer (28)
  5. Jonathan Rosenberg (26)
  6. Hikmat Al-Ahmadie (23)

More People

Years
  1. 2023 (5)
  2. 2022 (5)
  3. 2021 (2)
  4. 2020 (6)
  5. 2019 (5)
  6. 2018 (6)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. JCO Precision Oncology (1)

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ancestry-adjusted genomic analysis to identify known and novel associations with single and multiple cancer phenotypes
    Meeting Abstract

    Joseph, V.; Ravichandran, V.; Ostrovnaya, I.; Liu, Y. L.; Tkachuk, K.; Khurram, A.; Kemel, Y.; Mandelker, D.; Bandlamudi, C.; Walsh, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Mohamadpour, M.; Sherman, E. J.; Kriplani, A.; Fetten, J. V.; Dunn, L.; Michel, L. S.; Hung, K. W.; Baxi, S. S.; McDonald, E.; Conybeare, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Novel genetic subtypes of urothelial carcinoma with differential outcomes on immune checkpoint blockade
    Journal Article

    Sarfaty, M.; Golkaram, M.; Funt, S. A.; Al-Ahmadie, H.; Kaplan, S.; Song, F.; Regazzi, A.; Makarov, V.; Kuo, F.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Correlating HLA variants and the emergence of immune-related adverse events (irAEs) from ipilimumab/nivolumab (I/N) in patients (pts) treated on CheckMate 214
    Meeting Abstract

    Voss, M. H.; Shah, N. J.; Kalvin, H. L.; Lihm, J.; Li, H.; Kotecha, R. R.; Jarchum, I.; Vemula, S. V.; Gupta, S.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Teo, M. Y.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Donahue, T. F.; Goh, A. C.; Cha, E. K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of bladder carcinomas with glandular phenotype
    Journal Article

    Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meeting Abstract

    Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Incidence and clinical outcomes of HER2-altered bladder cancer (BC) patients (pts)
    Meeting Abstract

    Lattanzi, M.; Niederhausern, A.; Zheng, J.; Bahadur, N.; Nichols, C.; Barton, L.; Gandhi, F.; Chan, K.; Insinga, A.; Philip, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save